missing translation for 'onlineSavingsMsg'
Learn More

Novus Biologicals™ Imiquimod, TLR7 ligand

Applications: Functional, In vitro assay, Ligand Activation

Marke:  Novus Biologicals™ NBP2-26228

 Lernen Sie weitere Varianten dieses

Artikelnummer. 18625380

  • 402.00 CHF / 5 Milligramm
Verfügbar ab: 03-12-2024
Sie sich ein, um den Lagerbestand zu sehen
Entdecken Sie weitere Sonderangebote
Zum Warenkorb hinzufügen
Dieser Artikel kann nicht zurückgegeben werden. Rückgaberichtlinie anzeigen

Beschreibung

Beschreibung

Imiquimod, TLR7 ligand is an imidazoquinoline amine analog to guanosine. As a synthetic molecule of the Imidazoquinoline family, it has potent immunostimulatory activity. Imiquimod has been shown to activate only TLR7. This activation is MyD88 dependant and leads to the induction of the transcription factor NF-kB. Buffer: 125μg in 50μL of DMSO (formerly supplied in sterile water) Endotoxin Note: <0.001 EU/μg MW: 276.8
Spezifikation

Spezifikation

2.5 mg/mL
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
This product is useful for activation of TLR7 and stimulation of TLR7 has been achieved with 5 to 10μL. Use in ligand activation, functional, and in vitro reported in scientific literature (PMID 25957979)
Human/Mouse
C14H16N4, HCl
5 mg
Imiquimod, TLR7 ligand
Produktvorschläge

Produktvorschläge

Videos
Sicherheitsdatenblatt (SDS)
Dokumentation

Dokumentation

Zertifikate
Sonderangebote

Sonderangebote

For Research Use Only